Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study
Rougier, P., Lepille, D., Bennouna, J., Marre, A., Ducreux, M., Mignot, L., Hua, A., Mery-Mignard, D.Volume:
13
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdf259
Date:
October, 2002
Fichier:
PDF, 133 KB
english, 2002